Ticker
CARMCompany Name
CARISMA THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Market Capitalization | Price to Sales | Revenues |
---|---|---|---|
6/30/2025 | $ 11.49M | 1.07 | $ 10.77M |
3/31/2025 | $ 7.77M | 0.39 | $ 19.96M |
12/31/2024 | $ 12.95M | 0.66 | $ 19.63M |
9/30/2024 | $ 43M | 2.12 | $ 20.27M |
6/30/2024 | $ 37.43M | 1.81 | $ 20.71M |
3/31/2024 | $ 62.73M | 4.16 | $ 15.07M |
12/31/2023 | $ 86.82M | 5.82 | $ 14.92M |
9/30/2023 | $ 106.74M | 10.04 | $ 10.63M |
6/30/2023 | $ 238.89M | 5.1 | $ 46.8M |
3/31/2023 | $ 227.44M | 5.26 | $ 43.24M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Market Cap / Revenues
(=) P/S
P/S for CARISMA THERAPEUTICS INC is calculated as follows: Market Cap [ $ 143.57M ] / Revenues [ $ 11.24M ]
(=) P/S [ 12.78 ]
Minimum
Mar 31, 2025
Maximum
Jun 30, 2021
Average
Median
filtered constituents | 3.41K |
---|---|
min | 0 |
max | 11.15 |
average | 2.62 |
median | 1.97 |
std | 2.38 |